Liver Disease Clinical Trials

Showing 861-880 of 1,498 trials

Study of INT-747 as Monotherapy in Participants With Primary Biliary Cirrhosis (PBC)

NCT00570765

The primary hypothesis was that obeticholic acid (OCA) will cause a reduction in alkaline phosphatase levels in PBC participants, over a 12-week treatment period, as compared to placebo.

Liver Cirrhosis, Biliary

Intercept Pharmaceuticals60 participantsStarted Jan 2008

Detroit, Michigan, United States • Houston, Texas, United States • Richmond, Virginia, United States +18 more locations

UNKNOWN

The Timing of Emergency Endoscopy for Esophagogastric Variceal Bleeding in Cirrhosis

NCT04932200

This study is a prospective, multi-center and observational clinical study. Investigators would like to explore the optimal emergency endoscopy timing in cirrhosis patients with esophagogastric variceal bleeding (EGVB) by evaluating and comparing the efficacy and safety of emergency endoscopy performed at different times ( within 6 hours or between 6 and 24 hours after gastroenterologic consultation ) and its impact on the short-term prognosis.

Liver CirrhosisPortal HypertensionEsophageal Varix Bleeding

Renmin Hospital of Wuhan University608 participantsStarted Jun 2021

Wuhan, Hubei, China

Study of INT-747 as Monotherapy in Participants With Primary Biliary Cirrhosis (PBC)

The Timing of Emergency Endoscopy for Esophagogastric Variceal Bleeding in Cirrhosis

Related Searches

Inspiratory Muscle Training Post-Liver Transplant

Evaluation of Albumin and Midodrine Versus Albumin Alone in Outcome of Refractory Ascites in Patients With Decompensated Cirrhosis.

THE FRENCH NATIONAL NAFLD COHORT (FRench pAtients With MEtabolic Steatosis)

Exercise Intervention in Liver Transplant Candidates

Cysteamine Bitartrate Delayed-Release for the Treatment of NAFLD in Children

Antimicrobial Resistance in Cirrhotic Patients

PPIs and Gastroesophageal Varices in Liver Cirrhosis (PPIs: Proton Pump Inhibitors)

Avatrombopag in Patients With End-stage Liver Disease and Thrombocytopenia

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BLD-0409 in Healthy Subjects

Study to Evaluate MET409 Alone or in Combination With Empagliflozin in Patients With Type 2 Diabetes and NASH

Anti-LPS Antibody Treatment for Pediatric NAFLD

Study of PD/PK/PG Relationships of Tacrolimus and Cyclosporin in Liver Transplant Patients

Initiation of Diet in Esophageal Varices After Ligation (IDEAL) Study

NASH in Subjects With Different Classes of Obesity

A Phase 1a/1b Study of CB4211 in Healthy Non-obese Subjects and Subjects With Nonalcoholic Fatty Liver Disease

Omegaven Protocol:Intermediate Size Patient Population

Phase 3 Study of Obeticholic Acid in Patients With Primary Biliary Cirrhosis

Lifestyle Modification for MAFLD Based on TTM